Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phases
AddedJun 25, 2026
UpdatedJul 6, 2026
Phases

Phases

Seed

Phases is a clinical-trial software company whose AI agents help sites recruit and schedule patients.

HQ
San Francisco, CA, US
Accelerator
Y Combinator logoY CombinatorS25
Overview
Compare
Fundraising
Employees

Phases builds AI agents for clinical-trial operations. Its first agent, Polly, connects to research-site systems to automate medical-record reviews, shorten patient screening conversations, and schedule eligible participants directly onto calendars. The product targets the recruitment bottleneck that slows drug development, where manual back-office work often delays enrollment.

The company sells to research sites, contract research organizations, and pharmaceutical sponsors. It competes in the eClinical and clinical-trial automation market alongside vendors that digitize trial management, and makes money by replacing or augmenting manual recruitment and coordination workflows with software.

Phases - Similar Companies

Convexia logo

Convexia

convexia.bio

Careforce logo

Careforce

careforce.ai

Delineate logo

Delineate

delineate.pro

HealthKey logo

HealthKey

gethealthkey.com

Baseline AI logo

Baseline AI

baselinetrials.com

Panoptive logo

Panoptive

panoptive.com

Simplex logo

Simplex

simplex.sh

Vela logo

Vela

tryvela.ai

Dodo logo

Dodo

dodo.ai

Synthio Labs logo

Synthio Labs

synthiolabs.com

Unisson logo

Unisson

unisson.ai

Perfectly logo

Perfectly

perfectly.so

PathPilot logo

PathPilot

getpathpilot.com

Gleam logo

Gleam

joingleam.com

Lab0 logo

Lab0

lab0.ai

Phases - Quick Facts

Who are Phases' competitors?

Companies similar to Phases include Convexia, Careforce, Delineate and HealthKey.

Where is Phases' headquarters located?

Phases' headquarters is located in San Francisco, CA, US.

When was Phases' last funding round?

Phases' most recent funding round was for $500k (USD) in June 2025.

How much has Phases raised to-date?

As of Jun 1, 2025, Phases has raised a total of $500k (USD).